Imunologia

Acute At Home Management of Anaphylaxis During The Covid-19 Pandemic-32315792.pdf

Cascada del complemento en pacientes con covid-19_SEI.pdf

Clinical and immunological features of severe and moderate coronavirus disease 2019-32217835.pdf

Clinician Wellness During the COVID-19 Pandemic_Extraordinary Times and Unusual Challenges for the Allergist_Immunologist-32259628.pdf

Complement as a target in COVID-19?_Comment.pdf

Coronavirus infections_Epidemiological, clinical and immunological features and hypotheses-32292881.pdf

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York_32348641.pdf

COVID-19 pathophysiology_A review-[In press].pdf

COVID-19_Pandemic Contingency Planning for the Allergy and Immunology Clinic-32224232.pdf

Covid19 rapid guideline_children and young people who are immunocompromised-Guia NICE.pdf

How Do We Decide to De-Isolate COVID-19 Patients-32299784.pdf

Immune Thrombocytopenic Purpura in a Patient with Covid-19-32294340.pdf

Immunity after sars-cov-2 infection Norwegian Institute of Public Health

Immunity passports in the context of covid-19-OMS.pdf

Información general y cuestiones inmunológicas relevantes del Covid-19_SEI.pdf

Información sobre los test de detección de anticuerpos_SEI.pdf

Interpretacion de las pruebas diagnosticas frente a Sars-CoV-2-Ministerio de Sanidad-Socieda Española de enfermedades Infecciosas y Microbiologia Clinica.pdf

Long-lived Effector_Central Memory T-cell Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) S Antigen in Recovered SARS Patients-16781892.pdf

Neutralizing Antibodies Against SARS-CoV-2 and Other Human Coronaviruses-32249063.pdf

Plasma IP-10 and MCP-3 Levels Are Highly Associated With Disease Severity and Predict the Progression of COVID-19-32360286.pdf

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies-32106567.pdf

Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists-32352407.v1.pdf

Privileges and Immunity Certification during the COVID-19 Pandemic-32374358 .pdf

Profile of a Killer_The Complex Biology Powering the Coronavirus Pandemic-32367025.pdf

Recomendaciones para el abordaje de estudios de Inmunofenotipado en pacientes con infección COVID-19_SEI.pdf

Recomendaciones para solicitar la determinación de los niveles de citocinas en suero de pacientes con Covid-19_SEI.pdf

Recomendaciones para solicitar la determinación de los niveles de IL-6 en suero en pacientes con Covid-19_SEI.pdf

Recomendaciones relativas a la transferencia de plasma. Inmunoterapia pasiva a pacientes con COVID-19_SEI.pdf

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy-32253068.pdf

Revisión Narrativa Sobre La Respuesta Inmunitaria Frente A Coronavirus: Descripción General, Aplicabilidad Para Sars-Cov2 E Implicaciones Terapéuticas_pre proof.pdf

SARS Coronavirus Redux-32173256.pdf

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor-32142651.pdf

SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion_32265513.pdf

Serum Neopterin for Early Assessment of Severity of Severe Acute Respiratory Syndrome-15925828.pdf

Systematic Review of the Efficacy and Safety of Antiretroviral Drugs Against SARS, MERS or COVID-19_Initial Assessment-32293807.pdf

The immunological case for staying active during the COVID-19 pandemic-32311497.pdf

The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19)_The Perspectives of Clinical Immunologists From China-32222466.pdf

Why are pregnant women susceptible to COVID-19 An immunological viewpoint-32244166.pdf